Serious Perinatal Complications of Non-Proteinuric Hypertension: An International, Multicentre, Retrospective Cohort Study
The DOI matches its Crossref record; 41 of the 44 references it cites were found in a registry or an index.
Abstract
Objective To determine the proportion of births complicated by either a pre-existing or a gestational non-proteinuric hypertension, presenting at <34 weeks' gestation, and the associated incidence with 1 or more serious perinatal complications or birth weight <3rd centile for gestational age.Methods A retrospective chart review was conducted in 5 international centres, from 1998 to 2002, where "tight" control (normalization) of blood pressure (BP) is the norm. International Classification of Diseases (ICD) codes were used to identify women who delivered at > or =20 weeks' gestation, with any hypertensive disorder of pregnancy. Women were included if they had a diastolic blood pressure (dBP) of 90 to 109 mm Hg, due to either a pre-existing or a gestational non-proteinuric hypertension, presenting at <34 weeks' gestation. Women were excluded if they had ongoing severe hypertension, or if at presentation with dBP of 90 to 109 mm Hg, they had 1 or more of the following: proteinuria, an indication for "tight" control of BP or imminent delivery, or a known intrauterine fetal death or lethal fetal anomaly. Data were collected on paper forms, scanned into an electronic database, and summarized descriptively by type of hypertension.Results There were 305 eligible women (0.7% deliveries, 12.8% hypertensive deliveries) identified with non-proteinuric hypertension that was either pre-existing (133 [43.6%]) or gestational (172 [56.4%]). Regardless of hypertension type, 16.4% (n = 50) of pregnancies were complicated by birth weight <3rd centile or 1 or more serious perinatal complications, 34.3% (n = 100) by preterm birth, 30.8% (n = 94) by preeclampsia, and 2.0% (n = 6) by serious maternal complications.Conclusion Non-proteinuric pre-existing or gestational hypertension, presenting before 34 weeks' gestation, identifies a subpopulation of hypertensive pregnant women at both substantial perinatal risk and maternal risk. The CHIPS (Control of Hypertension In Pregnancy Study) trial is designed to determine how best to manage the hypertension of such women in order to optimize perinatal outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertension in a preconceptional woman increases the risk of adverse outcomes during pregnancy, especially her risk of developing preeclampsia (55).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [55]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Papile, L.-A., Burstein, J., Burstein, R., & Koffler, H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80282-0 · Cited by 6,430
(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
A New and Improved Population-Based Canadian Reference for Birth Weight for Gestational Age
Kramer, M. S., Platt, R. W., Wen, S. W., Joseph, K. S., Allen, A., Abrahamowicz, M., Blondel, B., Bréart, G., & for the Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System (2001) · Pediatrics · doi:10.1542/peds.108.2.e35 · Cited by 1,524
The classification and definition of the hypertensive disorders of pregnancy
Davey, D. A., & MacGillivray, I. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90090-7 · Cited by 1,288
Shennan, A. T., Dunn, M. S., Ohlsson, A., Lennox, K., & Hoskins, E. M. (1988) · Pediatrics · doi:10.1542/peds.82.4.527 · Cited by 1,254
Self-citationFetal programming and adult health
Godfrey, K. M., & Barker, D. J. (2001) · Public Health Nutrition · doi:10.1079/phn2001145 · Cited by 995
von Dadelszen, P., Ornstein, M., Bull, S., Logan, A., Koren, G., & Magee, L. (2000) · The Lancet · doi:10.1016/s0140-6736(98)08049-0 · Cited by 518
Self-citationSibai, B. M., Lindheimer, M., Hauth, J., Caritis, S., VanDorsten, P., Klebanoff, M., MacPherson, C., Landon, M., Miodovnik, M., Paul, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391004 · Cited by 500
Strauss, R. S. (2000) · JAMA · doi:10.1001/jama.283.5.625 · Cited by 434
Research works printed but not linked: 4
- Catalano, 1997, Valuazione della monoterapia con nifedipina nel management della gestosi EPH [Evaluation of nifedipine monotherapy in the management of pregnancy hypertension], Giorn It Ost Gin, 6, 373
- Odendaal HJ, Schabort I, Pattinson RC. Prazosin for the treatment of hypertension in pregnancy: a randomized control trial [database on CD-ROM]. Version 1. 2 (Disk Issue 6). Oxford Database of Perinatal Trials 1991.
- Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1 2003. Oxford: Update Software.
- Sibai, 1986, Pregnancy outcome of intensive therapy in severe hypertension in first trimester, Obstet Gynecol, 67, 517
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003018 · Cited by 878
RETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Magee, L. A., Helewa, M., Rey, E., Cardew, S., Côté, A.-M., Douglas, M. J., Firoz, T., Gibson, P. S., Gruslin A., A., Lange, I., et al. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32776-1 · Cited by 578
“One third of women with gestational hypertension at <34 weeks will develop preeclampsia over an average of 5 weeks; delivery is unlikely within 7 days [65].”
BackgroundSelf-citationDiabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
“Hypertension in a preconceptional woman increases the risk of adverse outcomes during pregnancy, especially her risk of developing preeclampsia (55).”
Metadata
- Authors
- Magee, L. A., von Dadelszen, P., Bohun, C. M., Rey, E., El-Zibdeh, M., Stalker, S., Ross, S., Hewson, S., Logan, A. G., Ohlsson, A., Naeem, T., Thornton, J. G., Abdalla, M., Walkinshaw, S., Brown, M., Davis, G., & Hannah, M. E.
- Affiliations
- University of British Columbia (CA)
- University College Cork (IE)
- Islamic Hospital (JO)
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- University of Leeds (GB)
- University of Nottingham (GB)
- University of Liverpool (GB)
- UNSW Sydney (AU)
- Sunnybrook Health Science Centre (CA)
- Venue
- Journal of Obstetrics and Gynaecology Canada
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 25
- Issue
- 5
- Pages
- 372-382
- ISSN
- 1701-2163 (ISSN-L)
- OpenAlex
- W2416723877
- Cited by
- 77
- References
- 44
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 2
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Obstetrics and Gynaecology Canada (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
- Keywords
- gestational hypertension, hypertensive disorders of pregnancy, perinatal complications, preterm birth, preeclampsia, low birth weight, fetal growth restriction, maternal complications, tight blood pressure control, antihypertensive therapy in pregnancy
- MeSH terms
- Adult, Birth Weight, Female, Fetal Death, Gestational Age, Humans, Hypertension, Infant, Newborn, Infant, Small for Gestational Age, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Retrospective Studies, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serious Perinatal Complications of Non-Proteinuric Hypertension: An International, Multicentre, Retrospective Cohort Study. https://app.cochat.ai/papers/10.1016/s1701-2163(16)30579-5
- The paper
- Magee, L. A., von Dadelszen, P., Bohun, C. M., Rey, E., El-Zibdeh, M., Stalker, S., Ross, S., Hewson, S., Logan, A. G., Ohlsson, A., Naeem, T., Thornton, J. G., Abdalla, M., Walkinshaw, S., Brown, M., Davis, G., & Hannah, M. E. (2003). Serious Perinatal Complications of Non-Proteinuric Hypertension: An International, Multicentre, Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Canada. https://doi.org/10.1016/s1701-2163(16)30579-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.